← All trials
NCT04789356
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 18, 2021
- Primary completion
- Jul 5, 2021
- Completion date
- Mar 31, 2022
- First posted
- Mar 9, 2021
- Last posted
- Jul 26, 2021
- Enrollment
- 6233
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Fundação de Medicina Tropical Dr. Heitor Vieira DouradoLead sponsor
- Butantan InstituteCollaborator
- Fundação de Medicina Tropical Dr. Heitor Vieira DouradoOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.